TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 44 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Quantum Private Wealth, LLC | 359,367 | $286,632 | 0.16% |
Sands Capital Ventures, LLC | 724,873 | $579,898 | 0.14% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,500,000 | $1,196,400 | 0.12% |
Nantahala Capital Management | 1,722,400 | $1,350,706 | 0.10% |
Artal Group S.A. | 1,440,882 | $1,149 | 0.07% |
CARLSON CAPITAL L P | 504,000 | $401,990 | 0.04% |
Redwood Wealth Management Group, LLC | 37,750 | $30,109 | 0.03% |
Alphabet Inc. | 640,882 | $512,706 | 0.03% |
XTX Topco Ltd | 85,167 | $67,929 | 0.01% |
CORNERCAP INVESTMENT COUNSEL INC | 55,359 | $44,154 | 0.01% |
Laurion Capital Management LP | 1,292,600 | $1,030,978 | 0.01% |
Camelot Portfolios, LLC | 11,000 | $8,774 | 0.01% |
Virtu Financial LLC | 45,459 | $36 | 0.00% |
Sargent Investment Group, LLC | 19,569 | $15,068 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 156,300 | $124,665 | 0.00% |
GSA CAPITAL PARTNERS LLP | 27,338 | $22 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 405,301 | $321 | 0.00% |
Tower Research Capital LLC (TRC) | 7,255 | $6 | 0.00% |
JPMORGAN CHASE & CO | 1,782 | $1,000 | 0.00% |
Renaissance Technologies | 249,600 | $199 | 0.00% |
External links
This page lists TAYSHA GENE THERAPIES INC's shareholders in Q1 2023. To view TAYSHA GENE THERAPIES INC's shareholder history, click here.